Virtu Financial’s BioCardia BCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20,355
Closed -$25K 1609
2026
Q1
$25K Buy
+20,355
New +$25.5K ﹤0.01% 1367
2024
Q2
Sell
-937
Closed -$6K 1318
2024
Q1
$6K Sell
937
-1,820
-66% -$13K ﹤0.01% 1281
2023
Q4
$27K Buy
+2,757
New +$22.4K ﹤0.01% 1271
2022
Q1
Sell
-3,761
Closed -$109K 1497
2021
Q4
$109K Buy
+3,761
New +$138K 0.01% 1097
2021
Q3
Sell
-2,218
Closed -$132K 1507
2021
Q2
$132K Buy
+2,218
New +$135K 0.01% 1127

Other funds holding BCDA

Virtu Financial's BCDA Position: Q2 2026 in Review

Virtu Financial sold out of BioCardia (BCDA) in Q2 2026, closing a stake of 20,355 shares — an estimated $25K sold.

Virtu Financial first reported a position in BCDA in Q2 2021 and held it in 5 quarters. The position peaked at $132K in Q2 2021. 21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

  • Virtu Financial reported no remaining BioCardia position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 20,355 BioCardia shares in Q2 2026, an estimated $25K.
  • Virtu Financial first reported a position in BioCardia in Q2 2021 and held it in 5 quarters.
  • Virtu Financial's BioCardia position peaked at $132K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.